Cargando…
Recent developments in multiple sclerosis therapeutics
Multiple sclerosis, the most common neurologic disorder of young adults, is traditionally considered to be an inflammatory, autoimmune, demyelinating disease of the central nervous system. Based on this understanding, the initial therapeutic strategies were directed at immune modulation and inflamma...
Autores principales: | Spain, Rebecca I, Cameron, Michelle H, Bourdette, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224941/ https://www.ncbi.nlm.nih.gov/pubmed/19968863 http://dx.doi.org/10.1186/1741-7015-7-74 |
Ejemplares similares
-
Recent developments in Alzheimer's disease therapeutics
por: Rafii, Michael S, et al.
Publicado: (2009) -
Protocol for an exploratory, randomised, single-blind clinical trial of aerobic exercise to promote remyelination in multiple sclerosis
por: Wooliscroft, Lindsey, et al.
Publicado: (2023) -
Falls in People with Multiple Sclerosis Compared with Falls in Healthy Controls
por: Mazumder, Rajarshi, et al.
Publicado: (2014) -
Predicting Falls in People with Multiple Sclerosis: Fall History Is as Accurate as More Complex Measures
por: Cameron, Michelle H., et al.
Publicado: (2013) -
Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives
por: Kim, Young Jin, et al.
Publicado: (2023)